COMPOUNDS, COMPOSITIONS AND METHODS
The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or prodrug thereof, and methods of making and using thereof.
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
27.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or prodrug thereof, and methods of making and using thereof. |
---|---|
AbstractList | The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or prodrug thereof, and methods of making and using thereof. |
Author | LEXA, Katrina W SWEENEY, Zachary K CRAIG, Robert A., II OSIPOV, Maksim FENG, Jianwen A DE VICENTE FIDALGO, Javier ESTRADA, Anthony A |
Author_xml | – fullname: SWEENEY, Zachary K – fullname: FENG, Jianwen A – fullname: ESTRADA, Anthony A – fullname: CRAIG, Robert A., II – fullname: DE VICENTE FIDALGO, Javier – fullname: OSIPOV, Maksim – fullname: LEXA, Katrina W |
BookMark | eNrjYmDJy89L5WRQdvb3DfAP9XMJ1lEAM4M9Qzz9_YIVHP1cFHxdQzz8XYJ5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CJkYmFpZmpo5ExEUoACKckUA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSÉS, COMPOSITIONS ET PROCÉDÉS VERBINDUNGEN, ZUSAMMENSETZUNGEN UND VERFAHREN |
ExternalDocumentID | EP4248965A2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP4248965A23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:46:33 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP4248965A23 |
Notes | Application Number: EP20230173466 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230927&DB=EPODOC&CC=EP&NR=4248965A2 |
ParticipantIDs | epo_espacenet_EP4248965A2 |
PublicationCentury | 2000 |
PublicationDate | 20230927 |
PublicationDateYYYYMMDD | 2023-09-27 |
PublicationDate_xml | – month: 09 year: 2023 text: 20230927 day: 27 |
PublicationDecade | 2020 |
PublicationYear | 2023 |
RelatedCompanies | Denali Therapeutics Inc |
RelatedCompanies_xml | – name: Denali Therapeutics Inc |
Score | 3.489704 |
Snippet | The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | COMPOUNDS, COMPOSITIONS AND METHODS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230927&DB=EPODOC&locale=&CC=EP&NR=4248965A2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8oqD0yaJt2rR5KLI1LVXoB7aTvY3GpbCXOVzFf99r6KYv-nYkcEkOfveR5O4AbilxRdu92DDJ3DFsKiqD1ezBkNIxqfRoTVS7tySl8cR-njrTHiw2uTCqTuiXKo6IiHpDvDdKX69-LrG4-lu5vhcLHHp_jEqf6110jP40s1ydj_0wz3gW6EGAlJ6--LZle4w6I9TWO-hFuy0Ywtdxm5Sy-m1RokPYzZHZsjmCnlwOYD_YNF4bwF7SvXcj2UFvfQw3QZbk2STlxZ2myOJJZQBro5RrSVjGGS9OQIvCMogNXG22PdkszLf7IqfQx4BfnoHmCMmsORXEQ39KWqYgFbOZNAWtK2Z6dAjDP9mc_zN3AQetiNrfDpZ7Cf3m41NeoUltxLUSxjfzG3Zd |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsX5WVD6ZNE2bdo8DNmajk7XD2wneyuNy2Avc7iK_77XsE1f9O1I4JIc_O4jyd0B3FLiirp7sWGSqWPYVJQGm7EHQ0rHpNKjM6LavUUxDcf208SZNGC-yYVRdUK_VHFERNQb4r1S-nr5c4nF1d_K1b2Y49D74yDvcn0dHaM_zSxX5_1ukCY88XXfR0qPX7q2ZXuMOj3U1jvoYbs1GILXfp2UsvxtUQYHsJsis0V1CA25aEPL3zRea8NetH7vRnINvdUR3PhJlCbjmGd3miKzocoA1nox16IgDxOeHYM2CHI_NHC1YnuyIki3-yIn0MSAX56C5gjJrCkVxEN_SlqmICWzmTQFnZXM9GgHOn-yOftn7hpaYR6NitEwfj6H_Vpc9c8Hy72AZvXxKS_RvFbiSgnmG6poeVA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS%2C+COMPOSITIONS+AND+METHODS&rft.inventor=SWEENEY%2C+Zachary+K&rft.inventor=FENG%2C+Jianwen+A&rft.inventor=ESTRADA%2C+Anthony+A&rft.inventor=CRAIG%2C+Robert+A.%2C+II&rft.inventor=DE+VICENTE+FIDALGO%2C+Javier&rft.inventor=OSIPOV%2C+Maksim&rft.inventor=LEXA%2C+Katrina+W&rft.date=2023-09-27&rft.externalDBID=A2&rft.externalDocID=EP4248965A2 |